1. Home
  2. CORT vs PAYC Comparison

CORT vs PAYC Comparison

Compare CORT & PAYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • PAYC
  • Stock Information
  • Founded
  • CORT 1998
  • PAYC 1998
  • Country
  • CORT United States
  • PAYC United States
  • Employees
  • CORT N/A
  • PAYC N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • PAYC Computer Software: Prepackaged Software
  • Sector
  • CORT Health Care
  • PAYC Technology
  • Exchange
  • CORT Nasdaq
  • PAYC Nasdaq
  • Market Cap
  • CORT 7.6B
  • PAYC 9.0B
  • IPO Year
  • CORT N/A
  • PAYC 2014
  • Fundamental
  • Price
  • CORT $80.94
  • PAYC $164.03
  • Analyst Decision
  • CORT Strong Buy
  • PAYC Buy
  • Analyst Count
  • CORT 5
  • PAYC 13
  • Target Price
  • CORT $139.00
  • PAYC $225.42
  • AVG Volume (30 Days)
  • CORT 639.6K
  • PAYC 884.6K
  • Earning Date
  • CORT 11-04-2025
  • PAYC 11-05-2025
  • Dividend Yield
  • CORT N/A
  • PAYC 0.91%
  • EPS Growth
  • CORT N/A
  • PAYC N/A
  • EPS
  • CORT 0.87
  • PAYC 8.05
  • Revenue
  • CORT $741,172,000.00
  • PAYC $2,001,300,000.00
  • Revenue This Year
  • CORT $28.85
  • PAYC $10.98
  • Revenue Next Year
  • CORT $34.98
  • PAYC $9.14
  • P/E Ratio
  • CORT $91.92
  • PAYC $20.42
  • Revenue Growth
  • CORT 17.92
  • PAYC 9.72
  • 52 Week Low
  • CORT $49.00
  • PAYC $156.50
  • 52 Week High
  • CORT $117.33
  • PAYC $267.76
  • Technical
  • Relative Strength Index (RSI)
  • CORT 61.15
  • PAYC 35.37
  • Support Level
  • CORT $73.79
  • PAYC $158.00
  • Resistance Level
  • CORT $78.99
  • PAYC $163.51
  • Average True Range (ATR)
  • CORT 3.03
  • PAYC 5.49
  • MACD
  • CORT 0.61
  • PAYC 0.52
  • Stochastic Oscillator
  • CORT 95.41
  • PAYC 38.13

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

Share on Social Networks: